Clinical Trial Update: Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing continuous subcutaneous insulin infusion (CSII) with basal-bolus multiple daily injections in type 2 diabetes to assess efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED